The DOI matches its Crossref record; 111 of the 116 references it cites were found in a registry or an index.
Central Hypothyroidism: Pathogenic, Diagnostic, and Therapeutic Challenges
Abstract
CONTEXT: Central hypothyroidism (CH) is a particular hypothyroid condition due to an insufficient stimulation by TSH of an otherwise normal thyroid gland. This condition raises several challenges for clinicians; therefore, a review of the most relevant findings on CH epidemiology, pathogenesis, and clinical management has been performed. METHODOLOGY: The relevant papers were selected by a PubMed search using appropriate key words. MAIN FINDINGS: CH can be the consequence of various disorders affecting either the pituitary gland or the hypothalamus, but most frequently affecting both of them. CH is about 1000-fold rarer than primary hypothyroidism. Except for the neonatal CH due to biallelic TSHβ mutations, the thyroid hormone defect is rarely as profound as can be observed in some primary forms. In contrast with primary hypothyroidism, CH is most frequently characterized by low/normal TSH levels, and adequate thyroid hormone replacement is associated with the suppression of residual TSH secretion. Thus, CH often represents a clinical challenge because physicians cannot rely on the systematic use of the "reflex TSH strategy." The clinical management of CH is further complicated by the frequent combination with other pituitary deficiencies and their substitution.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Several other drugs (e.g., glucocorticoids, anti-epileptics, somatostatin) have transient or controversial TSH-suppressive effects [1, 38] (see Table 3).”
From 2018 European Thyroid Association (ETA) Guidelines on the Diagnosis and Management of Central Hypothyroidism (2018) · cites this paper as [1]
In the citing paper
“However, a major limitation remains—the lack of assay specificity to distinguish between the bioactive TSH secreted in primary hypothyroidism versus the biologically inactive TSH isoforms typically secreted in central hypothyroidism.”
In the citing paper
“Secondary and tertiary hypothyroidism are often referred to as central hypothyroidism, and both central and extrathyroidal hypothyroidism account for less than 1% of cases worldwide.54”
From Hypothyroidism (2024) · cites this paper as [54]
In the citing paper
“Manifestations of CeH are similar to those of primary hypothyroidism, but they can be masked by coexistent MPHD [1, 24, 25].”
From 2018 European Thyroid Association (ETA) Guidelines on the Diagnosis and Management of Central Hypothyroidism (2018) · cites this paper as [1]
In the citing paper
“This condition is the consequence of anatomic or functional disorders of the pituitary gland (secondary hypothyroidism) or the hypothalamus (tertiary hypothyroidism) causing variable alterations of TSH secretion [1, 2].”
From 2018 European Thyroid Association (ETA) Guidelines on the Diagnosis and Management of Central Hypothyroidism (2018) · cites this paper as [1]
12 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Hollowell, J. G., Staehling, N. W., Flanders, W. D., Hannon, W. H., Gunter, E. W., Spencer, C. A., & Braverman, L. E. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.2.489 · Cited by 4,279
Cooper, D. S., & Biondi, B. (2012) · The Lancet · doi:10.1016/s0140-6736(11)60276-6 · Cited by 1,039
Update of Newborn Screening and Therapy for Congenital Hypothyroidism
American Academy of Pediatrics, Rose, S. R., and the Section on Endocrinology and Committee on Genetics, American Thyroid Association, Brown, R. S., and the Public Health Committee, & Lawson Wilkins Pediatric Endocrine Society (2006) · Pediatrics · doi:10.1542/peds.2006-0915 · Cited by 798
Andersen, S., Pedersen, K. M., Bruun, N. H., & Laurberg, P. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.3.8165 · Cited by 686
Hypothalamic-pituitary dysfunction after radiation for brain tumors
Constine, L. S., Woolf, P. D., Cann, D., Mick, G., McCormick, K., Raubertas, R. F., & Rubin, P. (1993) · New England Journal of Medicine · doi:10.1056/nejm199301143280203 · Cited by 619
Caturegli, P., Newschaffer, C., Olivi, A., Pomper, M. G., Burger, P. C., & Rose, N. R. (2005) · Endocrine Reviews · doi:10.1210/er.2004-0011 · Cited by 588
Self-formation of functional adenohypophysis in three-dimensional culture
Suga, H., Kadoshima, T., Minaguchi, M., Ohgushi, M., Soen, M., Nakano, T., Takata, N., Wataya, T., Muguruma, K., Miyoshi, H., et al. (2011) · Nature · doi:10.1038/nature10637 · Cited by 498
Thyrotropin-Secreting Pituitary Tumors*
BECK-PECCOZ, P., BRUCKER-DAVIS, F., PERSANI, L., SMALLRIDGE, R. C., & WEINTRAUB, B. D. (1996) · Endocrine Reviews · doi:10.1210/edrv-17-6-610 · Cited by 491
Self-citationMechanisms behind the non-thyroidal illness syndrome: an update
Warner, M. H., & Beckett, G. J. (2010) · Journal of Endocrinology · doi:10.1677/joe-09-0412 · Cited by 432
A Mutation in the Thyroid Hormone Receptor Alpha Gene
Bochukova, E., Schoenmakers, N., Agostini, M., Schoenmakers, E., Rajanayagam, O., Keogh, J. M., Henning, E., Reinemund, J., Gevers, E., Sarri, M., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1110296 · Cited by 379
Research works printed but not linked: 1
- Persani, 2012, Central hypothyroidism, 560
Cited by
Global epidemiology of hyperthyroidism and hypothyroidism
Taylor, P. N., Albrecht, D., Scholz, A., Gutierrez-Buey, G., Lazarus, J. H., Dayan, C. M., & Okosieme, O. E. (2018) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2018.18 · Cited by 1,552
Chaker, L., Bianco, A. C., Jonklaas, J., & Peeters, R. P. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30703-1 · Cited by 1,159
Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline
Fleseriu, M., Hashim, I. A., Karavitaki, N., Melmed, S., Murad, M. H., Salvatori, R., & Samuels, M. H. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2118 · Cited by 945
Epigenetic regulation in metabolic diseases: mechanisms and advances in clinical study
Wu, Y.-L., Lin, Z.-J., Li, C.-C., Lin, X., Shan, S.-K., Guo, B., Zheng, M.-H., Li, F., Yuan, L.-Q., & Li, Z.-H. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01333-7 · Cited by 476
“These diseases include obesity,(3) type 2 diabetes (T2D),(4) nonalcoholic fatty liver disease (NAFLD),(5) osteoporosis,(6) gout,(7) hyperthyroidism(8) and hypothyroidism.(9) Diabetes has become the ninth major cause of death worldwide.”
BackgroundHypothyroidism in Context: Where We’ve Been and Where We’re Going
Chiovato, L., Magri, F., & Carlé, A. (2019) · Advances in Therapy · doi:10.1007/s12325-019-01080-8 · Cited by 459
Metadata
- Authors
- Persani, L.
- Affiliations
- University of Milan (IT)
- Corresponding author
- Persani, Luca
- ORCID
- Persani, Luca
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2012-09-01
- Volume
- 97
- Issue
- 9
- Pages
- 3068-3078
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2004260518
- Semantic Scholar
- 4548bf36df8fba0df7b332473f63c79f41e5cb60
- Cited by
- 295
- References
- 116
- Citations by year
- 2026: 14 · 2025: 28 · 2024: 18 · 2023: 21 · 2022: 22 · 2021: 26 · 2020: 16 · 2019: 32 · 2018: 25 · 2017: 20 · 2016: 21 · 2015: 18 · 2014: 23 · 2013: 9
- FWCI
- 2.22
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Università degli Studi di Milano
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- central hypothyroidism, TSH deficiency, pituitary disorders, hypothalamic disorders, neonatal hypothyroidism, thyroid hormone replacement, TSH suppression, pituitary hormone deficiency
- MeSH terms
- Humans, Hypothyroidism, Thyroid Hormones, Thyrotropin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Central Hypothyroidism: Pathogenic, Diagnostic, and Therapeutic Challenges. https://app.cochat.ai/papers/10.1210/jc.2012-1616
- The paper
- Persani, L. (2012). Central Hypothyroidism: Pathogenic, Diagnostic, and Therapeutic Challenges. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jc.2012-1616
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.